Table I.
Summary of GPCRs investigated in this study
| GPCR | GPCR family | MM (kDa) | Abbreviation | UniprotKB | PTMs |
|---|---|---|---|---|---|
| μ Opioid receptor | Class A | 44.5 | MOR | P33535 (OPRM_RAT) | 5 Phosphorylation sites 5 N‐Glycosylation sites 1 Palmytoylation site 1 Disulfide bond |
| Metabotropic glutamate receptor 1 | Class C | 132.4 | GRM1 | Q13255 (GRM1_HUMAN) | 4 N‐Glycosylation sites 5 Disulfide bonds |
| Glucagon‐like peptide 1 receptor | Class B | 53.0 | GLP1R | P43220 (GLP1R_HUMAN) | 3 N‐Glycosylation sites 4 Disulfide bonds |
| G‐protein coupled receptor 56 | Class B | 77.7 | GPR56 | Q9Y653 (GPR56_HUMAN) | 7 N‐Glycosylation sites |
| Thyrotrophic receptor | Class A | 86.8 | TSHR | P16473 (TSHR_HUMAN) | 6 N‐Glycosylation sites 2 Disulfide bonds |
| C‐X‐C chemokine receptor type 4 | Class A | 39.7 | CXCR4 | P61073 (CXCR4_HUMAN) | 3 Sulfation sites 8 Phosphorylation sites 2 N‐Glycosylation sites 1 O‐Glycosylation site 2 Disulfide bonds |
| C‐X‐C chemokine receptor type 5 | Class A | 41.9 | CXCR5 | P32302 (CXCR5_HUMAN) | 2 N‐Glycosylation sites 1 Disulfide bond |
MM, molecular mass; PTMs, posttranslational modifications.